208 related articles for article (PubMed ID: 6933485)
1. Antibodies from myasthenic patients that compete with cholinergic agents for binding to nicotinic receptors.
Fulpius BW; Miskin R; Reich E
Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4326-30. PubMed ID: 6933485
[TBL] [Abstract][Full Text] [Related]
2. alpha-Bungarotoxin displacing antibody in myasthenia gravis.
Barkas T; Simpson JA
J Clin Lab Immunol; 1982 Nov; 9(2):113-7. PubMed ID: 7154056
[TBL] [Abstract][Full Text] [Related]
3. Kinetic studies on neurotoxin-binding inhibitory antibodies in myasthenia gravis.
Ito A; Furukawa S; Satoyoshi E; Sakurai H
Clin Chim Acta; 1985 Nov; 152(3):315-23. PubMed ID: 2998645
[TBL] [Abstract][Full Text] [Related]
4. Functional inhibition of acetylcholine receptors by antibodies in myasthenic sera.
Hall ZW; Pizzighella S; Gu Y; Vicini S; Schuetze SM
Ann N Y Acad Sci; 1987; 505():272-85. PubMed ID: 2446552
[No Abstract] [Full Text] [Related]
5. A modified assay for antibody against the nicotinic acetylcholine receptor in myasthenia gravis.
Dwyer DS; Bradley RJ; Oh SJ; Kemp GE
Clin Exp Immunol; 1979 Sep; 37(3):448-51. PubMed ID: 509779
[TBL] [Abstract][Full Text] [Related]
6. Anti-acetylcholine receptor antibodies directed against the alpha-bungarotoxin binding site induce a unique form of experimental myasthenia.
Gomez CM; Richman DP
Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4089-93. PubMed ID: 6575398
[TBL] [Abstract][Full Text] [Related]
7. alpha-Bungarotoxin binding to the nicotinic acetylcholine receptor is inhibited by two distinct subpopulations of anti-receptor antibodies.
Barkas T; Gairns JM; Kerr HJ; Coggins JR; Simpson JA
Eur J Immunol; 1982 Sep; 12(9):757-61. PubMed ID: 7140813
[TBL] [Abstract][Full Text] [Related]
8. [Heterogeneity of antibodies blocking the binding of bungarotoxin to the acetylcholine receptor in myasthenia].
Vernet-der-Garabédian B; Morel E; Bach JF
C R Acad Sci III; 1984; 298(16):449-56. PubMed ID: 6428718
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the alpha-bungarotoxin receptor in chick-embryo retina.
Betz H
Eur J Biochem; 1981 Jun; 117(1):131-9. PubMed ID: 7262081
[TBL] [Abstract][Full Text] [Related]
10. Isolation of an antiidiotypic antibody with acetylcholine-receptor-like binding properties from myasthenia gravis patients.
Eng H; Lefvert AK
Ann Inst Pasteur Immunol; 1988; 139(5):569-80. PubMed ID: 3264701
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of antibodies directed against the alpha-bungarotoxin binding site on human acetylcholine receptor and severity of myasthenia gravis.
Vernet-der Garabedian B; Morel E; Bach JF
J Neuroimmunol; 1986 Jul; 12(1):65-74. PubMed ID: 3711314
[TBL] [Abstract][Full Text] [Related]
12. Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation.
Drachman DB; Angus CW; Adams RN; Michelson JD; Hoffman GJ
N Engl J Med; 1978 May; 298(20):1116-22. PubMed ID: 643030
[TBL] [Abstract][Full Text] [Related]
13. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
Kawanami S; Tsuji R; Oda K
Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal anti-acetylcholine-receptor antibodies directed against the cholinergic binding site.
Mochly-Rosen D; Fuchs S
Biochemistry; 1981 Sep; 20(20):5920-4. PubMed ID: 7295707
[TBL] [Abstract][Full Text] [Related]
15. [Heterogeneity of acetylcholine receptor antibodies in patients with myasthenia gravis].
Kalies I; Heinz F; Kaschka WP; Druschky KF; Kalden JR
Klin Wochenschr; 1984 Apr; 62(8):377-85. PubMed ID: 6727277
[TBL] [Abstract][Full Text] [Related]
16. The binding site for alpha-bungarotoxin resides in the sequence 188-201 of the alpha-subunit of acetylcholine receptor: structure, conformation and binding characteristics of peptide [Lys] 188-201.
Gotti C; Mazzola G; Longhi R; Fornasari D; Clementi F
Neurosci Lett; 1987 Nov; 82(1):113-9. PubMed ID: 3696481
[TBL] [Abstract][Full Text] [Related]
17. Immunologic similarities between the hypothalamic alpha-bungarotoxin receptor and the Torpedo californica nicotinic cholinergic receptor.
Block GA; Billiar RB
Brain Res; 1979 Dec; 178(2-3):381-7. PubMed ID: 509210
[TBL] [Abstract][Full Text] [Related]
18. Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins.
Appel SH; Anwyl R; McAdams MW; Elias S
Proc Natl Acad Sci U S A; 1977 May; 74(5):2130-4. PubMed ID: 266734
[TBL] [Abstract][Full Text] [Related]
19. Interaction of myasthenic immunoglobulins and cholinergic agonists on acetylcholine receptors of rat myotubes.
Ashizawa T; Elias SB; Appel SH
Ann Neurol; 1982 Jan; 11(1):22-7. PubMed ID: 6277235
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of an alpha-bungarotoxin receptor that forms a functional nicotinic channel.
Gotti C; Ogando AE; Hanke W; Schlue R; Moretti M; Clementi F
Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3258-62. PubMed ID: 2014250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
